Artificial-blood study has critics seeing red.
Guterman
Lila
L
D000046:Academic Medical Centers; D000552:Ambulances; D001802:Blood Substitutes / Q000627:therapeutic use; D001803:Blood Transfusion; D004345:Drug Industry; D015507:Drugs, Investigational; D004632:Emergency Medical Services / Q000941:ethics; D004638:Emergency Treatment / Q000941:ethics; D028744:Ethics Committees, Research; D006454:Hemoglobins; D006761:Hospitals; D006801:Humans; D007258:Informed Consent / Q000941:ethics* / Q000331:legislation & jurisprudence; D019724:Presumed Consent / Q000941:ethics*; D016032:Randomized Controlled Trials as Topic / Q000941:ethics* / Q000331:legislation & jurisprudence; D045808:Refusal to Participate; D036302:Therapeutic Human Experimentation / Q000941:ethics* / Q000331:legislation & jurisprudence; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration; D028761:Withholding Treatment / Q000941:ethics
D001802:Blood Substitutes; D015507:Drugs, Investigational; D006454:Hemoglobins; C509893:PolyHeme